Featured Research

from universities, journals, and other organizations

'Basal-like' breast cancer does not originate from basal stem cells

Date:
September 6, 2010
Source:
Cell Press
Summary:
New research uncovers a case of mistaken identity that may have a significant impact on future breast cancer prevention and treatment strategies. The study suggests that despite their "stem cell-like" characteristics, most aggressive breast tumors are not derived from normal mammary gland stem cells.

New research uncovers a case of mistaken identity that may have a significant impact on future breast cancer prevention and treatment strategies. The study, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, suggests that despite their "stem cell-like" characteristics, most aggressive breast tumors are not derived from normal mammary gland stem cells.

Related Articles


The glandular tissue of the breast contains two main cell types, outer "basal" cells and inner "luminal" cells. The basal layer consists mostly of differentiated cells with a small population of mammary stem cells. The luminal layer contains differentiated cells and several types of cells which are intermediates between the luminal cells and stem cells. The different cell types can be identified and separated on the basis of specific molecular markers.

"In breast cancer, it has been proposed that different tumor subtypes may originate from different stem and intermediate cells, with more aggressive 'basal-like' breast cancers originating from basal stem cells and less aggressive breast cancers from the luminal intermediates," explains senior study author, Dr. Matthew J. Smalley from The Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research in London. "Strikingly, the vast majority of breast tumors with mutations in BRCA1, a breast cancer susceptibility gene, have basal-like characteristics, suggesting a stem cell origin."

More recently, however, it was demonstrated that increases in abnormal luminal intermediate cells are associated with BRCA1 mutations and that there are similarities between the genes switched on in normal human luminal intermediate cells and basal-like breast cancer cells. "To resolve the true origin of BRCA1 breast cancer, we designed the first direct comparison of the effects of creating identical BRCA1-associated tumor predisposing events in basal stem versus luminal intermediate cells," says Dr. Smalley.

Specifically, the researchers deleted the BRCA1 gene in mouse basal stem cells or luminal intermediate cells. They discovered that although BRCA1 deletion caused tumors to form from both basal stem cells and luminal intermediate cells, only the latter had features that were identical to both human BRCA1 tumors and the majority of human basal-like breast cancers not associated with BRCA1 mutations.

Taken together, these findings suggest that the majority of so-called basal-like breast cancers are derived from luminal intermediate cells and not from basal stem cells as was originally expected. "Our results highlight luminal intermediate cells as a key to understanding the origins of basal-like breast cancer," concludes Dr. Smalley. "This has important implications for treatment and prevention strategies for this aggressive disease."

The reseachers include Gemma Molyneux, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK; Felipe C. Geyer, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK; Fiona-Ann Magnay, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK; Afshan McCarthy, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK; Howard Kendrick, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK; Rachael Natrajan, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK; Alan MacKay, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK; Anita Grigoriadis, Breakthrough Breast Cancer Research Unit, Guy's Hospital, King's Health Partners AHSC, London, UK; Andrew Tutt, Breakthrough Breast Cancer Research Unit, Guy's Hospital, King's Health Partners AHSC, London, UK; Alan Ashworth, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK; Jorge S. Reis-Filho, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK; and Matthew J. Smalley, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gemma Molyneux, Felipe C. Geyer, Fiona-Ann Magnay, Afshan McCarthy, Howard Kendrick, Rachael Natrajan, Alan MacKay, Anita Grigoriadis, Andrew Tutt, Alan Ashworth, Jorge S. Reis-Filho, Matthew J. Smalley. BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells. Cell Stem Cell, 2010; 7 (3): 403-417 DOI: 10.1016/j.stem.2010.07.010

Cite This Page:

Cell Press. "'Basal-like' breast cancer does not originate from basal stem cells." ScienceDaily. ScienceDaily, 6 September 2010. <www.sciencedaily.com/releases/2010/09/100902121043.htm>.
Cell Press. (2010, September 6). 'Basal-like' breast cancer does not originate from basal stem cells. ScienceDaily. Retrieved January 30, 2015 from www.sciencedaily.com/releases/2010/09/100902121043.htm
Cell Press. "'Basal-like' breast cancer does not originate from basal stem cells." ScienceDaily. www.sciencedaily.com/releases/2010/09/100902121043.htm (accessed January 30, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, January 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Oxfam Calls for Massive Aid for Ebola-Hit West Africa

Oxfam Calls for Massive Aid for Ebola-Hit West Africa

AFP (Jan. 29, 2015) Oxfam International has called for a multi-million dollar post-Ebola "Marshall Plan", with financial support given by wealthy countries, to help Guinea, Sierra Leone and Liberia to recover. Duration: 01:10 Video provided by AFP
Powered by NewsLook.com
Are We Winning The Fight Against Ebola?

Are We Winning The Fight Against Ebola?

Newsy (Jan. 29, 2015) The World Health Organization announced the fight against Ebola has entered its second phase as the number of cases per week has steadily dropped. Video provided by Newsy
Powered by NewsLook.com
Calif. Health Officials Campaign Against E-Cigarettes

Calif. Health Officials Campaign Against E-Cigarettes

Newsy (Jan. 29, 2015) The California Health Department says e-cigarettes are a public health risk for both smokers and those who inhale e-cig smoke secondhand. Video provided by Newsy
Powered by NewsLook.com
Measles Scare Sends 66 Calif. Students Home

Measles Scare Sends 66 Calif. Students Home

AP (Jan. 29, 2015) Officials say 66 students at a Southern California high school have been told to stay home through the end of next week because they may have been exposed to measles and are not vaccinated. (Jan. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins